EP3444261
2,2-Díflúoróprópíónamíð afleiða af bardoxólón metýl, lyfjasamsetningar og fjölbrigðaform þar af til notkunar við meðhöndlun tiltekinna sjúkdóma
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.4.2013EP published:
13.1.2021EP application number:
17175885.7
EP translation filed:
23.2.2021Grant published:
15.3.2021EPO information:
European Patent Register
Max expiry date:
23.4.2033Expiry date:
23.4.2026Next due date:
30.4.2026
Title:
2,2-DIFLUOROPROPIONAMIDE DERIVATIVE OF BARDOXOLONE METHYL, PHARMACEUTICAL COMPOSITIONS AND POLYMORPHS THEREOF FOR USE IN TREATING CERTAIN CONDITIONS
Timeline
Today
24.4.2013EP application
13.1.2021EP Publication
23.2.2021Translation submitted
15.3.2021Registration published
23.4.2026Expires
Owner
Name:
Reata Pharmaceuticals Holdings, LLCAddress:
5320 Legacy Drive, Plano, Texas 75024, US
Inventor
Name:
ANDERSON, EricAddress:
Southlake, TX 76092, US
Name:
DECKER, AndreaAddress:
4055 Basel, CH
Name:
LIU, XiaofengAddress:
Coppell, TX 75019, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261687669 PDate:
27.4.2012Country:
US
Number:
201361775288 PDate:
8.3.2013Country:
US
Number:
201361780444 PDate:
13.3.2013Country:
US
Classification
Categories:
C07J 63/00, A61K 31/565, A61P 29/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 8.4.2021
Expires: 23.4.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.4.2022
Expires: 23.4.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 12.4.2023
Expires: 23.4.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 10.4.2024
Expires: 23.4.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 8.4.2025
Expires: 23.4.2026
Payer: Árnason Faktor ehf.